In addition, in hematological neoplasma, most of the current studies believe that PLK2 acts as a tumor suppressor, and the kinase activity of PLK2 is also involved in the pathological mechanism of neurodegenerative diseases such as PD. The gene discussed is PLK2; the disease is Parkinson disease.